Organon Business Development
Partnering with Organon. We believe in a better and healthier every day for every woman.
“We’re committed to leadership in women’s health, expanding our general medicines portfolio, and building upon our global presence. At Organon, we believe in the power of collaboration. Working together, we can achieve far more for patients.”
Daniel Karp, Head of Corporate Development and Chief Strategy Officer
We aspire to be the partner of choice in our areas of focus
Women's health
We are committed to building a pipeline and portfolio of products to address her underserved needs. We seek opportunities in the areas of contraception, fertility, maternal and peripartum, and conditions that are unique to women or impact her differently.
General Medicines: Biosimilars
Our goal is to become the world class, global commercial partner of choice to biosimilar manufacturers and to expand our portfolio in oncology, immunology and beyond. We seek opportunities to commercialize biosimilars with near-term launches.
General Medicines: Established Brands
Organon is dedicated to helping patients manage critical, chronic, and acute conditions. We are committed to expanding patient access to medications by exploring new indications, markets and populations. Our focus areas include dermatology, cardiovascular health, neurology, respiratory and non-opioid pain management. We seek collaborations that are synergistic with our infrastructure and capabilities.
Key business development contacts
Daniel Karp
Head of Corporate Development and Chief Strategy Officer
Carol Ferguson
U.S. & Women’s Health Business Development
Troy Silfies
International & General Medicines Business Development
Abby Zhou
China Business Development
Satbir Kaur
Alliance Management & Integration
Parambir Bhangu
Search & Evaluation
To reach out for any other purpose, please visit the contact us page.